Stabilized Spherical Amorphous Calcium Carbonate Particles

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing amorphous calcium carbonate particles have limited stability, high basicity, and are difficult to process industrially, limiting their use as additives or modifiers in various applications due to rapid conversion into crystalline modifications.

Innovation Solution

Development of spherical, amorphous calcium carbonate particles with reduced structural water content and improved stability, achieved through specific synthesis conditions and stabilization with surface-active substances, resulting in particles with enhanced long-term stability and low basicity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If conventional amorphous calcium carbonate particles are prepared by reacting calcium chloride with carbonate sources, then spherical particles with variable water content are obtained, but their stability is limited and they transform into crystalline modifications rapidly

Engineering Contradiction:
Improvestability of amorphous calcium carbonate particlesVSAvoidshelf life of particles
Core Design Contradiction:
Stability of the object's compositionVSDuration of action of stationary object

Solution Approach 1:

The patent applies parameter changes by controlling the water content to be less than 0.4 mol per mol of calcium carbonate through specific synthesis conditions. This parameter control prevents rapid crystallization and extends the stability of the amorphous phase, resolving the contradiction between obtaining spherical particles and maintaining their stability over time.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If amorphous calcium carbonate particles are prepared with conventional methods, then particles are obtained, but their high basicity makes their use in many applications difficult or impossible

Engineering Contradiction:
Improveapplicability in various industriesVSAvoidhigh basicity of particles
Core Design Contradiction:
Adaptability or versatilityVSObject-generated harmful factors

Solution Approach 1:

The patent reduces the basicity of calcium carbonate particles by controlling the synthesis parameters, specifically the water content and reaction conditions. This parameter optimization allows the particles to be used in applications where high basicity would be problematic, thereby expanding their adaptability across different industries while maintaining their functional properties.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If rapid processing is used to prevent crystallization of amorphous particles, then particle stability is maintained, but industrial processing becomes difficult or impossible

Engineering Contradiction:
Improveamorphous phase stabilityVSAvoidindustrial processability
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The patent applies preliminary action by pre-controlling the water content during synthesis to be less than 0.4 mol per mol of calcium carbonate. This preliminary control of the critical parameter (water content) stabilizes the amorphous phase in advance, allowing sufficient time for industrial processing operations without requiring extremely rapid processing speeds, thus resolving the contradiction between stability and ease of manufacture.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting calcium carbonate particles exhibit improved mechanical properties, easier processing, and broader applicability, with increased stability allowing for homogeneous dispersion in polymers and extended shelf life, while maintaining a low pH value for easier handling.

Implementation Method 1

The calcium carbonate particles are obtained by reacting calcium chloride with dialkyl carbonate in the presence of an alkali metal hydroxide in aqueous solution

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

The atoms in ACC do not form ordered structures, but rather an irregular pattern, thus exhibiting only short-range order and no long-range order. ACC is unstable and transforms into calcite at temperatures above 300°C. The presence of water accelerates this process, and crystallization occurs even at lower temperatures.

Methodology Applied
Scientific EffectPhase transition: Phase Change

Data Source

PatentEP2598579B1Spherical amorphous calcium carbonate particles
Publication Date: 2024.09.11 SCHAEFER KALK
  • EP2598579B1 patent drawingFigure 1
  • EP2598579B1 patent drawingFigure 2
  • EP2598579B1 patent drawingFigure 3

AI summary

The invention relates to stabilised, spherical, amorphous calcium carbonate particles having a mean particle diameter in the range from 0.05 μm to 2.0 μm and a water content of at most 5.0 wt %, based on the total weight thereof and measured as residual moisture at 200°C, wherein, a) the calcium carbonate particles comprise at least one substance which has a molar mass greater than 100 g/mol and satisfies the formula R-Xn, wherein the radical R represents a radical comprising at least one carbon atom, the radical X represents a group which comprises at least one oxygen atom and at least one carbon atom, sulphur atom, phosphorus atom and/or nitrogen atom and n preferably constitutes a whole number in the range from 1 to 20, b) the proportion of crystalline calcium carbonate is less than 30 wt %, based on the total weight of the calcium carbonate, and c) the specific surface area of the calcium carbonate particles is at most 20 m2/g. Preferred fields of application of the calcium carbonate particles include the use thereof as an additive or modifying agent in paper, paints, plastics, inks, adhesives and pharmaceuticals.